Literature DB >> 15696148

Shortening the treatment of tuberculosis.

Denis A Mitchison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15696148     DOI： 10.1038/nbt0205-187

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  9 in total

Review 1.  New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.

Authors:  Jossy van den Boogaard; Gibson S Kibiki; Elton R Kisanga; Martin J Boeree; Rob E Aarnoutse
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

2.  The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis.

Authors:  Srinivasa P S Rao; Sylvie Alonso; Lucinda Rand; Thomas Dick; Kevin Pethe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

3.  Moxifloxacin Replacement in Contemporary Tuberculosis Drug Regimens Is Ineffective against Persistent Mycobacterium tuberculosis in the Cornell Mouse Model.

Authors:  Yingjun Liu; Henry Pertinez; Geraint R Davies; Stephen H Gillespie; Anthony R Coates; Yanmin Hu
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Deletion of pknG Abates Reactivation of Latent Mycobacterium tuberculosis in Mice.

Authors:  Mehak Zahoor Khan; Vinay Kumar Nandicoori
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 5.  Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Authors:  David J Horne; Sarah E Royce; Lisa Gooze; Masahiro Narita; Philip C Hopewell; Payam Nahid; Karen R Steingart
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

6.  In Vitro and In Vivo Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis.

Authors:  Shaochen Guo; Bin Wang; Lei Fu; Xi Chen; Weiyan Zhang; Haihong Huang; Yu Lu
Journal:  Antimicrob Agents Chemother       Date:  2021-08-16       Impact factor: 5.191

7.  High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.

Authors:  Yanmin Hu; Alexander Liu; Fatima Ortega-Muro; Laura Alameda-Martin; Denis Mitchison; Anthony Coates
Journal:  Front Microbiol       Date:  2015-06-23       Impact factor: 5.640

8.  Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome.

Authors:  Yuejuan Zheng; Xin Jiang; Feng Gao; Junxiang Song; Jinxia Sun; Lixin Wang; Xiaoxia Sun; Zhenhui Lu; Huiyong Zhang
Journal:  BMC Complement Altern Med       Date:  2014-10-15       Impact factor: 3.659

9.  Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model.

Authors:  Yanmin Hu; Henry Pertinez; Fatima Ortega-Muro; Laura Alameda-Martin; Yingjun Liu; Alessandro Schipani; Geraint Davies; Anthony Coates
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.